Open AccessThe Role of Cisapride in the Treatment of Pediatric Gastroesophageal Reflux
Author(s) -
Yvan Vandenplas,
Dominique C. Belli,
Avram Benatar,
Samy Cadranel,
Salvatore Cucchiara,
C. Dupont,
Frédéric Gottrand,
Eric Hassall,
H. S. A. Heymans,
Gregory L. Kearns,
C. M. F. Kneepkens,
S. Koletzko,
Peter J. Milla,
Isabel Polanco,
Annamaria Staiano
Publication year - 1999
Publication title -
journal of pediatric gastroenterology and nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.206
H-Index - 131
eISSN - 1536-4801
pISSN - 0277-2116
DOI - 10.1097/00005176-199905000-00017
Subject(s) - cisapride , medicine , prokinetic agent , qt interval , adverse effect , reflux , drug , gastroenterology , anesthesia , disease , pharmacology
Cisapride is a gastrointestinal prokinetic agent that is used worldwide in the treatment of gastrointestinal motility-related disorders in premature infants, full-term infants, and children. Efficacy data suggest that it is the most effective commercially available prokinetic drug.